Keyphrases
Nitric Oxide
100%
Thromboxane A2 (TXA2)
100%
Rat Colon
100%
Sodium Nitroprusside
62%
Irinotecan
37%
Platelet-activating Factor
37%
IC50
25%
Mucosa
25%
Carboxy-PTIO
25%
NO-cGMP Pathway
25%
Receptor Antagonist
12%
Epithelial Cells
12%
Concentration-dependent
12%
Stimulants
12%
Colonic mucosa
12%
Anticancer Drugs
12%
Membrane Potential
12%
Ussing Chamber
12%
Cyclic GMP
12%
NO Donors
12%
Thromboxane B2 (TXB2)
12%
Whole-cell Currents
12%
Colonic Crypt
12%
Guanylate Cyclase Inhibitor
12%
NO Scavenger
12%
Biochemistry, Genetics and Molecular Biology
Secretion (Process)
100%
Nitric Oxide
100%
Colon
100%
Thromboxane A2
100%
Platelet-Activating Factor
27%
IC50
18%
Mucosa
18%
Receptor Antagonist
9%
Membrane Potential
9%
Whole Cell
9%
Synthase
9%
Ussing Chamber
9%
Colon Mucosa
9%
Guanylate Cyclase
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Thromboxane A2
100%
Nitroprusside Sodium
62%
Irinotecan
37%
Thrombocyte Activating Factor
37%
IC50
25%
2 (4 Carboxyphenyl) 4,4,5,5 Tetramethylimidazoline 1 Oxyl 3 Oxide
25%
1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One
25%
Neoplasm
12%
Receptor Antagonist
12%
Synthetase
12%
Guanylate Cyclase Inhibitor
12%